Published in Ann Oncol on August 01, 1998
Osteosarcoma (osteogenic sarcoma). Orphanet J Rare Dis (2007) 2.53
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol (2015) 1.81
Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. J Cancer Res Clin Oncol (2005) 1.59
Current strategies of chemotherapy in osteosarcoma. Int Orthop (2006) 1.49
Frontline treatment of localized osteosarcoma without methotrexate: results of the St. Jude Children's Research Hospital OS99 trial. Cancer (2011) 1.11
Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy. Clinics (Sao Paulo) (2009) 1.05
Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv (2009) 1.02
Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults. Clin Orthop Relat Res (2008) 1.01
Pulmonary metastases in children with osteosarcoma: characteristics and impact on patient survival. Pediatr Radiol (2010) 0.97
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. J Transl Med (2013) 0.97
Cancer chemotherapy: targeting folic acid synthesis. Cancer Manag Res (2010) 0.95
Spontaneous malignant transformation of conventional giant cell tumor. Skeletal Radiol (2004) 0.95
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years. Acta Orthop (2011) 0.92
Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution. Clin Orthop Surg (2011) 0.92
Serum tumor markers in pediatric osteosarcoma: a summary review. Clin Sarcoma Res (2012) 0.90
Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome. Sarcoma (2014) 0.89
The survival of osteosarcoma patients 10 years old or younger is not worse than the survival of older patients: a retrospective analysis. Cancer Res Treat (2007) 0.87
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial. Curr Oncol (2010) 0.87
Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. BMC Cancer (2015) 0.83
A new method for repeated drug infusion into the femoral artery of mice. J Am Assoc Lab Anim Sci (2012) 0.82
Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma. Br J Cancer (2005) 0.81
Characterization of localized osteosarcoma of the extremity in children, adolescents, and young adults from a single institution in South Texas. J Pediatr Hematol Oncol (2014) 0.80
Clinical analysis of osteosarcoma patients treated with high-dose methotrexate-free neoadjuvant chemotherapy. Curr Oncol (2014) 0.80
A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma (2004) 0.79
What are the factors that affect survival and relapse after local recurrence of osteosarcoma? Clin Orthop Relat Res (2014) 0.79
What can we learn from geographical comparisons of childhood cancer survival? Br J Cancer (2007) 0.78
Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma. Clin Orthop Relat Res (2014) 0.78
Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma. Oncol Lett (2013) 0.77
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes. World J Surg Oncol (2014) 0.77
[Chemotherapy-induced changes in high grade central osteosarcomas-experiences gained through the assignment as reference-pathologists of the COSS-studies]. Pathologe (2004) 0.77
[Not Available]. Can Urol Assoc J (2009) 0.75
Preventing and Managing Toxicities of High-Dose Methotrexate. Oncologist (2016) 0.75
Association of MMP-2 expression and prognosis in osteosarcoma patients. Int J Clin Exp Pathol (2015) 0.75
Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma. Front Pharmacol (2017) 0.75
Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma. World J Surg Oncol (2012) 0.75
Osteosarcoma in Korean children and adolescents. Korean J Pediatr (2015) 0.75
Detection of somatostatin receptors in human osteosarcoma. World J Surg Oncol (2008) 0.75
A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes. J Orthop Surg Res (2017) 0.75
Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience. Front Oncol (2016) 0.75
A patient-derived orthotopic xenograft (PDOX) mouse model of a cisplatinum-resistant osteosarcoma lung metastasis that was sensitive to temozolomide and trabectedin: implications for precision oncology. Oncotarget (2017) 0.75
Orbital and millennial Antarctic climate variability over the past 800,000 years. Science (2007) 5.10
The leader peptide of yeast gene CPA1 is essential for the translational repression of its expression. Cell (1987) 4.91
Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell (2001) 4.36
Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A (1997) 4.25
Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol (2001) 4.18
A clinical pathway to accelerate recovery after colonic resection. Ann Surg (2000) 3.04
Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg (2000) 2.85
Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol (2006) 2.84
Heterogeneity in breast cancer and the problem of relevance of findings. Anal Cell Pathol (1999) 2.81
Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation. Bone Marrow Transplant (1999) 2.53
Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut (2003) 2.49
Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology (1998) 2.48
Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem (1998) 2.44
Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment. Lancet (1994) 2.42
Inactivation of the protein phosphatase 2A regulatory subunit A results in morphological and transcriptional defects in Saccharomyces cerevisiae. Mol Cell Biol (1992) 2.33
Osteosarcoma. Ann Oncol (2010) 2.30
Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J (1999) 2.29
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol (2000) 2.28
Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging (1994) 2.27
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol (1999) 2.25
Aneurysmal bone cyst. A population based epidemiologic study and literature review. Clin Orthop Relat Res (1999) 2.22
Ethical problems in medical practice. A protocol for the guidance of physicians. West J Med (1982) 2.19
A protein-protein interaction map of yeast RNA polymerase III. Proc Natl Acad Sci U S A (1999) 2.18
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol (1996) 2.13
Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer (1988) 2.11
The Gorham-Stout syndrome (Gorham's massive osteolysis). A report of six cases with histopathological findings. J Bone Joint Surg Br (1999) 2.07
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain (2000) 2.04
Fatal outcome in two girls with hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy. Med Pediatr Oncol (2000) 2.02
Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol (2001) 2.01
Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res (2001) 1.93
Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer (1988) 1.92
Suppression of yeast RNA polymerase III mutations by FHL1, a gene coding for a fork head protein involved in rRNA processing. Mol Cell Biol (1994) 1.91
Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial. Int J Radiat Oncol Biol Phys (1995) 1.87
Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer (2006) 1.85
Revision of the Kotz type of tumour endoprosthesis for the lower limb. J Bone Joint Surg Br (2002) 1.76
[Determination of the degree of morphological regression following chemotherapy in malignant bone tumors]. Pathologe (1983) 1.72
The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci U S A (1999) 1.69
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol (2003) 1.67
Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol (2001) 1.66
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy (2009) 1.66
Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet (1996) 1.65
From first base: the sequence of the tip of the X chromosome of Drosophila melanogaster, a comparison of two sequencing strategies. Genome Res (2001) 1.64
Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man. Br Med J (1974) 1.63
Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol (1996) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia (2005) 1.60
Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet (1999) 1.59
Gender bias in the assessment of physical activity in population studies. Soz Praventivmed (2001) 1.58
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57
Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol (1992) 1.57
Serum protein changes during the acute phase reaction. Clin Chim Acta (1969) 1.57
Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrob Agents Chemother (1992) 1.57
Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol (2001) 1.55
Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture. Bone (1992) 1.53
Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol (1996) 1.53
Anaerobic pericarditis: case report and review. Clin Infect Dis (1994) 1.52
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial. Br J Haematol (1998) 1.51
Dual role of the C34 subunit of RNA polymerase III in transcription initiation. EMBO J (1997) 1.51
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med (2000) 1.50
Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80. J Cancer Res Clin Oncol (1983) 1.49
Immunohistochemical detection of the c-erbB-2 proto-oncogene product in normal, benign and malignant cartilage tissues. Histopathology (1989) 1.48
The nature of giant cell tumor of bone. J Cancer Res Clin Oncol (2001) 1.47
Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol (1998) 1.47
Vertebra plana due to a Ewing tumor. Med Pediatr Oncol (1999) 1.45
A universally conserved region of the largest subunit participates in the active site of RNA polymerase III. EMBO J (1995) 1.45
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia (2000) 1.45
The yeast RNA polymerase III transcription machinery: a paradigm for eukaryotic gene activation. Cold Spring Harb Symp Quant Biol (1998) 1.45
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group. Leukemia (1998) 1.44
Chronic consumption coagulopathy due to an occult splenic haemangioma: Kasabach-Merritt syndrome. Eur J Pediatr (1995) 1.44
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
A segment of mRNA encoding the leader peptide of the CPA1 gene confers repression by arginine on a heterologous yeast gene transcript. Mol Cell Biol (1994) 1.43
Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clin Endocrinol (Oxf) (2007) 1.42
A long-term review of the treatment of patients with Ewing's sarcoma in one institution. Eur J Surg Oncol (2001) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol Cell Biochem (1998) 1.41
Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr Blood Cancer (2006) 1.41
Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol (2001) 1.41
Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg (2000) 1.41
Molecular diagnosis of a Mycobacterium chelonae infection. Pathol Res Pract (2001) 1.39
[Thoracic pain in a power athlete]. Internist (Berl) (1997) 1.39
Langerhans cell histiocytosis masquerading as lichen aureus. Pediatr Dermatol (1991) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol (1988) 1.39